PORT WASHINGTON, N.Y., Nov. 02, 2016 (GLOBE NEWSWIRE) -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sales and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that the date of the Company's conference call to discuss the operating and financial results for the first quarter of fiscal 2017, originally scheduled on November 4, 2016, has been changed to November 3, 2016. The earnings press release for the first quarter of fiscal 2017 was issued shortly after the market closed today. In addition, the Company issued a release announcing the acquisition of the generic products and related assets of Citron Pharma and Lucid Pharma shortly after the market closed today. Management will now host a conference call to discuss both the operating and financial results for the first quarter of fiscal 2017 and the transaction at 9:00 a.m. ET on Thursday, November 3, 2016. To participate in the conference call, please dial (800) 446-1671 or (847) 413-3362 approximately 10 minutes prior to the call. Please reference conference ID # 43519926. Management has also prepared a slide presentation which will accompany its prepared remarks. The presentation will be available for downloading under the Events and Presentations in the investor relations section of the Company's website, www.aceto.com. The call is also being webcast. Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software and download the presentation. A telephone replay of the conference call will be available from 11:30 a.m. ET on November 3, 2016 until 11:59 p.m. ET on November 11, 2016 and may be accessed by calling (888) 843-7419 and referencing conference ID # 43519926. An archived replay of the conference call will also be available in the investor relations section of the Company's website.